These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 501085)

  • 1. Relationship between Fc (IgG) receptors and alloantigens on the surface of BALB/c B cell lymphoma lines.
    Kanellopoulos-Langevin C; Kim KJ; Sachs DH; Asofsky R
    J Immunol; 1979 Dec; 123(6):2651-7. PubMed ID: 501085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of EA-rosette formation blockade by antisera against cell surface antigens].
    Bogdanova IM; Malaĭtsev VV
    Biull Eksp Biol Med; 1980 Oct; 90(10):453-6. PubMed ID: 7426708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenic and tumorigenic properties of a murine lymphoma that expresses foreign alloantigens: role of helper factor(s) in generating a cytotoxic response in vitro.
    Scott JW; Finke JH
    Transplant Proc; 1981 Dec; 13(4):1867-73. PubMed ID: 6800082
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological analysis of macrophage surface alloantigens.
    Mottram PL; Potter TA; McKenzie IF; Miller JF
    Cell Immunol; 1981 Mar; 59(1):151-60. PubMed ID: 6938312
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies on the expression of Fc-receptors, Ia antigens, and beta 2-microglobulin following in vitro herpes simplex virus infection of human lymphoid cells.
    Dorval G; Bourkas AE; Menezes J
    Clin Exp Immunol; 1979 Sep; 37(3):477-85. PubMed ID: 92381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the lymphocytic receptor binding immunoglobulin G Fc fragment].
    Nowak J
    Postepy Hig Med Dosw; 1981; 35(2):129-58. PubMed ID: 7038649
    [No Abstract]   [Full Text] [Related]  

  • 7. A cloned cell line, Mk1, possessing Ia antigens and accessory cell activity.
    Kyoizumi S; Noro N; Teshigawara K; Sakaguchi S; Masuda T
    J Immunol; 1982 Jun; 128(6):2586-94. PubMed ID: 6951877
    [No Abstract]   [Full Text] [Related]  

  • 8. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface markers of a purified peritoneal eosinophil population from Mesocestoides corti-infected BALB/c male mice.
    Hogarth PM; Cruise KM; McKenzie IF; Mitchell GF
    J Immunol; 1980 Jan; 124(1):406-11. PubMed ID: 6153100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of monoclonal anti-thy-1.2: comparison of monoclonal IgM and IgG with xeno-antithymocyte preparations.
    Sherburne CG; Condie RM
    Transplant Proc; 1981 Mar; 13(1 Pt 1):504-8. PubMed ID: 6973851
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of new murine lymphocyte alloantigens: antisera prepared between C57L, 129 and related strains define new loci.
    Potter TA; McKenzie IF
    Immunogenetics; 1981; 12(3-4):351-69. PubMed ID: 6162796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theta antigen and immunogolbulin on a tissue-cultured mouse lymphoma.
    Boylston AW
    Immunology; 1973 May; 24(5):851-7. PubMed ID: 4541405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
    Mathur A; Lynch RG; Köhler G
    J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants.
    Schirrmacher V; Jacobs W
    J Supramol Struct; 1979; 11(1):105-11. PubMed ID: 522481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human lymphocyte receptors for the Fc ends of IgG].
    Revillard JP; Samarut C; Cordier G; Lethibichthuy ; Cohen J; Brochier J
    C R Seances Soc Biol Fil; 1980; 174(4):686-701. PubMed ID: 6449247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxic cells against solid tumors in mice. III. A comparison of effector cell antigenic phenotype and target cell recognition structures with those of NK cells.
    Lattime EC; Pecoraro GA; Stutman O
    J Immunol; 1981 May; 126(5):2011-4. PubMed ID: 7217680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of FcR alpha on murine lymphocytes by IgA in vitro.
    Yodoi J; Adachi M; Masuda T
    J Immunol; 1982 Feb; 128(2):888-94. PubMed ID: 6976386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.